Figure 1. Figure 1. A new boron agent for the radiation-based treatment of glioblastoma. (IMAGE)
Caption
(A) Previously studied and (B) proposed boron agents used to deliver boron to tumor cells. The way in which the new boron agent PBC-IP binds to the carrier protein albumin facilitates its accumulation in tumor cells even at low doses, leading to better treatment outcomes without toxic effects on healthy cells.
Credit
Journal of Controlled Release
Usage Restrictions
Credit must be given to the creator. Only noncommercial uses of the work are permitted. No derivatives or adaptations of the work are permitted.
License
CC BY-NC-ND